Private Biotech firm Colossal wants to genetically re-create woolly mammoths to re-wild the arctic. It hopes to birth these hybrid creatures within six years in a bid to combat climate change. This...
biotechnology
Tiziana plans to list promising Accustem cancer test business on Nasdaq (TLSA) (TILS)
Tiziana Life Sciences (NASDAQ:TLSA | LSE: TILS) on Tuesday unveiled plans to list Accustem Sciences in the US on the Nasdaq Stock Market. This will give the spin-off access to a market with a...
Pharma’s $7.2 Billion CBD Acquisition Could Trigger New Biotech Boom
CARDIOL THERAPEUTICS INC. (TSX:CRDL | OTCQX:CRTPF | FRA:CT9) Giant $7.2 Billion Acquisition Validates CBD With Jazz Pharmaceuticals announcing they plan to acquire GW Pharmaceuticals for USD$7.2...
Special Report: 6 Reasons Why XPhyto Therapeutics Can Enhance Your Portfolio – (CSE:XPHY | OTC:XPHYF | FSE:4XT)
Huge biotech potential at XPhyto Therapeutics (CSE:XPHY | OTC:XPHYF | FSE:4XT) Biotechs are among the most profitable, highest-margin businesses on earth. Why? Exclusivity and first-mover advantage....
XPhyto (CSE:XPHY│OTC:XPHYF) – an exhilarating biotech company with Big Pharma potential!
Have you ever wondered how the Big Pharma companies got so big? Just look at some of their market caps. Roche (SWX:RO) is worth $290 billion. Novartis (SWX:NOVN) is worth $220 billion....